As a world-renowned international organization, the WHO's influence is absolutely unparalleled, especially in the field of health medicine, and basically their words represent absolute authority. In addition, Nature magazine also uses the topic of Deepin Technology Biological Research Laboratory as the cover of the new journal, which means that it is self-evident.

From the establishment of the WHO to the present, the Director-General has been so tireless in supporting a company's research project at the launch of the event.

This makes it impossible for everyone to ignore the new chimeric antigen receptor T-cell immunotherapy.

Almost before the press conference ended, reports of related content had already appeared on major overseas platforms.

It caused a new round of discussion among overseas netizens.

Originally, because of the deliberate dissemination of remarks by Pfizer, many people questioned this new technology.

I think the effect of that treatment is exaggerated.

Humanity is not yet able to completely solve this problem with cancer.

In addition, this technology is not developed by a company in my own country, so I will have some distrust in my heart.

But it was in this situation that Tan Said came to such a hand.

There is also proof from the journal Nature.

are telling them that this technology is real and effective.

No matter what kind of faith people have, they are all equal in the face of disease.

No one wants cancer to find themselves or their family.

If there is a chance of curing cancer, then they don't care which company is doing it.

As long as you can use it.

If someone knows that there is such a technology to cure cancer, but still prevents them from using it, please believe that the other party will definitely end badly.

And that's exactly what happened.

As more and more overseas netizens began to have their own judgments, the mastermind behind Ruihui Biotech has gradually been dug up, which can be said to have aroused the excitement of the crowd and said that they will no longer buy the drugs produced by Ruihui in the future, which will undoubtedly make things worse for Ruihui.

"Even the WHO and Nature have stated that it seems that this technology can indeed cure cancer."

"I have long said that Deepin Technology is a special company, how can it do things that damage its own image, and the effects that have been passed down must be real."

"I also saw Xu Yun in the video, there is no way to fake this genius."

"According to my friends in Jingzhou, many cancers have been successfully cured and discharged from the hospital, and the cost of treatment is much lower than traditional chimeric antigen receptor T-cell immunotherapy."

"It's great to be able to solve cancer, and hopefully this technology will be introduced sooner rather than later."

"Naturally, they are the most authoritative scientific journals, and they have proven that there is absolutely no problem."

"I said why there are so many people who question this technology all of a sudden, it turns out that the pharmaceutical company is behind it, and it is even more impossible to use his anti-cancer drugs now."

……

The number of cancer patients overseas is not small, and for patients who have taken anti-cancer drugs, they are well aware that the cost is not small.

After truly seeing the advantages of the new chimeric antigen receptor T-cell immunotherapy, I believe that even if they are allowed to use anti-cancer drugs, they will never accept and agree.

It can be said that from the moment the new chimeric antigen receptor T-cell immunotherapy was known, the era of traditional anti-cancer drugs has been announced, and no matter how many friends and partners Ruihui contacts to cooperate, it cannot stop the change and development of the situation.

Strictly speaking, Aibole also vaguely guessed some about the development of this matter.

I knew in my heart that it was only a matter of time before the company lost the global anti-cancer drug market, and it was nothing more than the length of time.

That's why he behaves relatively calmly when he explains his mission to Payina.

The expression on his face barely caused waves.

And the reason why he directly accepts the changes in the market every year is because he still has hope in his heart and is unwilling to let the company lose the market like this.

After all, the previous CEO of the company led the company to grow stronger.

A variety of special drugs have been developed.

When I got to him, I went straight downhill.

It's really hard to accept.

To that end, when Payina accepted the assignment and began to act, he stayed in his office and did nothing, keeping an eye on the Internet to see what would happen.

At first, when he saw that everyone had successfully questioned the new chimeric antigen receptor T-cell immunotherapy in the Deepin Technology Biological Research Laboratory, he was quite excited and excited, and felt that the situation was not without any room for maneuver for them.

As long as everyone deepens this kind of doubt, then it is unlikely that they will take that step and take the initiative to try it later.

In this way, most cancer patients will continue to choose anti-cancer drugs.

However, the plan really couldn't keep up with the changes, and no one thought that at this time, the WHO and Nature would suddenly take action.

And it's still so sharp as soon as it strikes.

In an instant, the wind reversed, completely shattering their advantage of going first.

At this moment, he watched the discussion on the platform, especially after he noticed that some people couldn't wait to use this technology, and he quickly realized that they had failed.

The failure was complete.

He was not surprised that Nature would use a topic from the DeepTech Biological Research Laboratory as the cover of a new journal, as this was not the first time they had announced Xu Yun's research results.

In addition, we will not let go of the far-reaching task of tackling cancer, no matter what the outcome is.

After all, major medical laboratories around the world deeply understand the difficulty of curing cancer.

There is a high probability that time and resources will be wasted.

So most of the time, I study from the perspective of treatment, and I don't think about curing at all.

Therefore, there are very few experimental teams willing to choose this kind of topic.

DeepTech's biological research laboratory can definitely be called a special case.

But it is surprising that WHO Director-General Chad Adhane Ghebreyesis so supportive of new chimeric antigen receptor T-cell immunotherapy, and has also taken the initiative to pay for this technology.

Even he didn't know when the other party came into contact with the DeepTech Biological Research Laboratory.

Of course, things are basically a foregone conclusion now, and nothing can be changed no matter what is said.

"I didn't expect to lose to a lab that was only a few years old, is it really that we are on the wrong path?"

Silently retracting his gaze from the computer screen, Ai Bole turned around and looked at the scenery behind him through the floor-to-ceiling window, and muttered to himself with a lonely expression that came to mind.

Deepin Technology has grown into a huge technology giant in the past few years since its establishment.

Among them, the biological research laboratory was built later.

There is no way to compare it with their Pfizer's pharmaceutical research lab.

Whether it's heritage or experience.

However, the other party has developed a new type of chimeric antigen receptor T cell immunotherapy and announced the victory over cancer.

On the other hand, they have been pacing in the field of anti-cancer drugs.

There is no attempt to find new cancer treatments.

In a way, it is inevitable to be surpassed today, who makes them not have the existence of Xu Yun.

Fortunately, it is worth mentioning that Aibole did not indulge in this loneliness for too long, after all, there are still many things left in the company that need to be handled by him, the CEO, otherwise Ruihui Biotech will really gradually withdraw from the stage.

Compared with other pharmaceutical companies, the volume of Pfizer Biotech is very large in the world.

Although the anti-cancer drugs developed by Ruihui are very famous, the company's business scope is relatively wide.

Even if the market for anti-cancer drugs is lost, it does not mean that the company will not be able to operate.

It's nothing more than a huge loss of profits.

The most important thing is what to do next to minimize the loss as much as possible.

At the same time, it makes a plan for the future development direction of the company.

The thought stayed here, and a large number of thoughts couldn't help but flash through his mind.

At this moment, he heard a slightly rapid knock on the door from outside the office, forcing him to disengage from his state of thought.

"Come in."

Ai Bole sat back down, raised his gaze to the door, and spoke.

The next second, I saw Paina, who was wearing a white women's suit, push open the office door and walked in quickly, and after stopping at a position more than ten centimeters away from the desk, she immediately opened her mouth to report the situation to the boss.

"Something happened, boss."

At first, he said this with a worried face, and then explained in detail without waiting for Ai Bole to ask.

"The WHO suddenly held a press conference, announcing that it would use the foundation's funds to purchase technology licenses from Deepin Technology, and would provide cancer treatment assistance to some areas."

"In addition, the cover of the latest issue of Nature magazine also uses the topic of new chimeric antigen receptor T cell immunotherapy with deep technology."

"It's very bad for our company, and now the situation has changed."

Paina said all of these words almost in one breath, and it could be seen that she was indeed very worried at the moment.

Originally, the boss gave her this task, wanting to protect the company's overseas anti-cancer drug market in this way, but this happened and the task failed directly.

It also indirectly caused the company to completely lose the market for anti-cancer drugs.

Naturally, her heart was full of guilt.

I always feel that I have betrayed the trust of my boss.

As soon as she learned of these circumstances, she immediately rushed back to the company and went to the boss's office to report to Aibole.

Thinking about whether new measures can be taken to remedy it.

Paina already knew what Ai Bole was talking about, so his expression didn't change after listening to it.

I always kept that calm state.

Instead, he pointed to the chair next to him and motioned for Paina to sit down first.

"Sit down."

Speaking of which, Payina thinks she knows enough about her boss, but in the face of the current situation, she can't help but have a question mark in her heart.

I don't know why the boss doesn't seem to pay much attention to it this time.

Know that this is a huge stake for the company.

If anti-cancer drugs are eliminated from the market, then all the R&D funds they previously invested will be wasted, and the key point is that the company will lose a money-making project in the future.

It stands to reason that in the face of this situation, we should have been in a hurry and thought of remedies everywhere.

But seeing that her boss was not joking, she had to sit down with patience no matter how confused she was.

But he didn't forget to continue to ask: "Boss, should we take rescue measures again?" ”

At this time, Ai Bole didn't bother to sell it, nodded in the face of Paina's inquiry and said, "I already know about this matter, I didn't expect the WHO to move so quickly." ”

"Boss, you already know?" Payina exclaimed.

As soon as she saw the news, she hurriedly ran over, facing her boss's calm and relaxed appearance, thinking that the other party didn't know the situation yet, so she hurriedly told everything that happened.

As a result, who would have thought that his boss would have known about it a long time ago.

"Then what should we do next, should we contact other pharmaceutical companies to discuss countermeasures?"

"There's no need for that." Hearing that Payina immediately brought the conversation back to business, Ebola shook her head in response.

"The influence of the new chimeric antigen receptor T cell immunotherapy in the DeepTech Biological Research Laboratory has exceeded its control, and the era of anti-cancer drugs is a thing of the past."

Paina didn't expect her boss to be so pessimistic all of a sudden, but she still didn't admit defeat and asked more.

"Is there really no other way?"

"Our anti-cancer drugs cannot be compared with each other's technology, and now with the intervention of international organizations, when the scale of this technology can meet the treatment of cancer patients around the world, no one will buy anti-cancer drugs."

"I believe that after today, other pharmaceutical companies will also understand." Ai Bole added a sentence at this point.

Listening to the boss's words, Payina couldn't help but fall into deep thought.

If you think about it, they really can't come up with any way to deal with it at the moment, and it seems that they can only accept it all.

But just as she was silent, the voice of Ai Bole came from her ears again.

"I've got a new assignment for you to do."

"New mission?" Payina was a little confused.

At this point, she couldn't think of any new tasks that she needed to complete.

Fortunately, her doubts did not last long, and the next second she listened to Ai Bole continue to speak: "I want to send you to Jingzhou City to strive for cooperation with Deepin Technology and obtain their technical authorization for a new chimeric antigen receptor T cell immunotherapy." When he spoke, his expression was solemn and his face was serious, not at all like a joke.

Payina listened to all of Ai Bole's words, and when she learned that she was going to go to Jingzhou City to cooperate with Deepin Technology, her first reaction was that she had heard it wrong.

But she soon reacted and understood the purpose of her boss's actions.

Now that it is certain that the market for anti-cancer drugs will no longer exist, it is necessary to find new ways for the company's subsequent development.

If there is one of the most promising businesses in the future, it must be a new chimeric antigen receptor T-cell immunotherapy.

It is true that the therapeutic effect of anticancer drugs is not as good as this therapy, but it is convenient and can quickly treat a large number of cancer patients.

However, the new chimeric antigen receptor T-cell immunotherapy will not work.

In any case, even if the new chimeric antigen receptor T cell immunity is effective in the cell modification and expansion process, it will require customized treatment injections for each patient.

This requires more laboratories capable of manufacturing this custom injection.

The best way for new chimeric antigen receptor T-cell immunotherapies to be rolled out globally is to license the technology and collaborate with qualified hospitals and laboratories around the world, so that these institutions can customize treatment plans for patients and reduce the number of cancers worldwide as quickly as possible.

Refizer has a strong enough lab to provide customized treatment for many cancer patients as long as it has access to novel chimeric antigen receptor T-cell immunotherapy technology.

At that time, as long as the cost of treatment is set, it will be able to gradually make up for the lost profits lost in the anti-cancer drug market.

There's an old saying, if you can't beat it, join in.

Paina immediately figured out what Aibole was trying to do, and knew it was the best choice for the company.

It's just that she was still a little worried in her heart, and she didn't immediately respond to the boss's assignment.

"But with our relationship with Deepin Technology, will the other party still agree to cooperate with us?"

Her concerns were justified.

Deepin Technology and Ruihui Biotech were obviously in competition before, not to mention that they used that kind of method later, it would be undoubtedly self-deception to say that Deepin Technology did not know at all.

After all, with the level of deep technology in artificial intelligence and quantum computing, it is really not difficult to know something.

In this case, it is normal for Deepin Technology to refuse to cooperate.

They are not the only world-renowned pharmaceutical companies, and Deepin Technology can fully cooperate with others.

In response to this situation, Ai Bole didn't know the bottom, but in order to let Paina regain her confidence, she had to say a few more words.

"Our cooperation with Deepin Technology is in response to the call of Director General Chai Tan Said, and we can use the identity of the other party to discuss cooperation with Deepin Technology, and we have already joined the Global Quantum Alliance, and in some respects we have already cooperated with this genius scientist."

"I believe that the other party will not give up on reaching cooperation with us because of the previous trivial matters."

After hearing Ai Bole's words, Payina finally gained some confidence, and immediately replied:

"Don't worry, boss, I will definitely do my best to reach this cooperation."

After speaking, he no longer hesitated, and immediately turned around and left to prepare.

In addition, this time it can be said that she has been assigned three important tasks in a row by the boss, but unfortunately the first two missions were unsuccessful, so this time she can be said to have made a lot of determination.

It has to be done no matter what.

……

……

Soon into the new January, with the announcement of the official opening of new cancer treatment departments in big city hospitals such as Yangcheng and Shenzhen, the imperial capital, the level of successfully accepting cancer patients has finally reduced the pressure on Jingzhou a lot.

To this end, Xu Yun also sent Ding Wei and Zhou Lihua over to ensure that there would be no problems in the early stage of operation.

Although it is not yet possible to meet the needs of cancer patients across the country, it is fortunate that new departments will be opened in a new batch of cities, which will effectively relieve the pressure.

In addition, relying on Tan Said's appeal, overseas representatives also came to discuss cooperation.

I hope to be able to get the technical authorization of Deepin Technology.

Because this was in Xu Yun's plan, he naturally would not refuse this.

In the end, the consensus reached was that every time the other party uses this new technology to treat cancer patients, it needs to take a certain percentage of the treatment cost as the technology licensing fee of Deepin Technology.

As for the cost of treatment overseas, it is not his concern.

After all, Deepin Technology has limited strength, and he can only ensure that domestic cancer patients can be treated at the lowest cost.

Of course, the cost of treatment in Jingzhou is not a secret, and if the overseas price is too high, others will definitely not agree.

In addition, the places that choose to cooperate with Deepin Technology have also specially dispatched personnel to learn technology.

Among them, Tan Said also specially sent Bei Luming over.

This shows how much the other party attaches great importance to the grand ideal of completely eradicating cancer.

It is also worth mentioning that Xu Yun is not worried about anyone defaulting at all.

Anyway, they are all members of the Global Quantum Alliance, and they really dare to do this unless they want to be removed from the Quantum Alliance, and they will no longer be able to use the computing power of Zu Chongzhi's No. 3 quantum computing.

——

"Let me introduce you to Ms. Payina of Pfizer Biotech."

"I also want to cooperate with Deepin Technology this time."

July 3, 2024, Jingzhou City, Lounge of Biological Research Laboratory of Longhu Science and Technology Park.

Bei Luming first introduced the identity of the blonde woman in front of Xu Yun, and then turned his head and smiled and said, "Ms. Payina, this is Mr. Xu Yun, the most genius scientist in mankind who has created deep technology. ”

"I have heard about Mr. Xu Yun's achievements for a long time, and today I am finally fortunate to be able to meet the real person, and I hope that we at Ruihui can also contribute to the action of eradicating cancer around the world." Pa Yina took the initiative to reach out and shake Xu Yun's hand, without hiding the curiosity and heat in her eyes.

After all, in the face of such a young man full of miracles, I believe that anyone will not be able to control their curiosity.

It seems that Xu Yun is full of all kinds of secrets, and people can't help but want to find out.

After taking over the task arranged by her boss, Payina made some special preparations before taking a plane to Jingzhou.

It is worth mentioning that she did not come directly to Xu Yun, but first found Bei Luming, who is a member of the executive committee.

Let the other person act as an introducer.

Bei Luming is naturally aware of the strength of Ruihui Biotech, and if it can reach a cooperation with Deepin Technology, it will undoubtedly be able to provide customized injection treatment for a large number of cancer patients in a short period of time.

So after he learned about Payina's intentions, he agreed to be the introducer without even thinking about it.

At this moment, Xu Yun looked carefully at this working woman with a strong aura, and didn't say much.

He was very clear about the things that Ruihui Biotech did, but he didn't pay attention to it.

It is nothing more than for the sake of the company's development, not to mention that it has no impact on Deepin Technology.

Therefore, he did not reject anything when Ruihui Biotech came to seek cooperation.

After beckoning a few people to sit down, he said directly: "Ms. Payina should know that we have cooperated with several overseas agencies, so there is nothing to talk about the relevant treaty, and you can sign the contract if you can accept it." ”

After listening to Xu Yun's words, Payina seemed to be calm on the surface, but in fact, she was shocked in her heart.

I didn't expect this trip to go so smoothly.

There are even those who can't believe it.

More than once before she came, she rehearsed in her mind what might happen.

Even the difficulties of deep technology.

In this regard, she is also ready to increase the technical licensing fee and accept certain harsh conditions.

In short, we must cooperate no matter what.

As a result, what she thought about had no chance to come in handy, and Xu Yun agreed to cooperate so easily.

Of course, she wouldn't blame Bei Luming for this matter, she could only say that Xu Yun was far different from what she thought.

In this case, where did she dare to question, naturally she hurriedly opened her mouth to express her attitude.

"We are willing to accept it."

Xu Yun nodded when he heard this, but he didn't say anything.

Of course, he didn't mean to give preferential treatment to Ruihui Biotech, the main cooperation standards with overseas are the same, and he is too lazy to waste time with Paina in this kind of thing.

With this effort, you can treat a cancer patient.

Although several other big cities now have the ability to use new chimeric antigen receptor T-cell immunotherapy to treat patients, which has reduced the pressure on biological research laboratories a lot, Ding Wei and Zhou Lihua are also not in Jingzhou City at the moment, and he still needs to be responsible for many things in the laboratory.

And he feels that the tasks on the board have been almost completed, and maybe one day he will get the task reward.

He was looking forward to it.

Determine Paina's attitude, and Xu Yun will no longer need to be involved in the rest of the matter, just hand it over to the company's special department to connect with the other party.

But at this time, I saw Wang Dong, who was the researcher's assistant, suddenly running in.

And also gasping for air, apparently running all the way.

During Xu Yun's time in the laboratory, he basically asked Wang Dong to help him as his assistant, knowing that the other party was still relatively stable when he usually did things.

Suddenly rushed over today, there must have been a relatively unexpected situation.

The thought stayed here, and he didn't hesitate, and hurriedly asked, "Why are you in such a hurry, what's wrong?" ”

"Xu Yuan."

"Academician Christian suddenly fainted and has now been sent to the First Hospital for treatment."

Faced with Xu Yun's inquiry, Wang Dong took a slight breath and answered quickly.

"Fainted?"

Hearing Wang Dong mention Christian, Xu Yun quickly stood up from the chair and frowned slightly.

Christian is a member of the Norwegian Academy of Sciences, whose main research area is biological genes, and he has previously come to Beijing to present him with the Abel Prize in Mathematics.

The other party is a relatively kind old man, and this time he came to discuss and learn because of the new chimeric antigen receptor T-cell immunotherapy.

If something really happens to the other party, it is really difficult to explain it to the other party's academy of sciences.

Thinking of this, Xu Yun no longer hesitated, and immediately turned his head to Pa Yina next to him and said, "Ms. Pa Yina, I will arrange for someone to dock with you in the future, and I will deal with the emergency situation today." ”

After speaking, he will take Wang Dong and leave, and he will go to the hospital to see how the situation is.

And Bellumin apparently knew Christian as well, and followed suit: "I'll go with you." ”

Soon, when only Pa Yina and her assistant were left in the lounge, the other party seemed to have made some decision, and quickly got up to keep up with Xu Yun and Bei Luming.

"Let's go too."

The cooperation negotiation went so smoothly, and it was not good for her to stay alone when this kind of thing happened suddenly.

It's better to go over with you to earn a good feeling.

By the time Xu Yun and his entourage arrived at the First Hospital of Jingzhou City, Christian had already completed the corresponding examinations, but what made people couldn't help frowning a little was that it was Lin Yi who was in charge.

It's not that Lin Yi is bad, the main thing is that he appears here as the deputy chief physician of the oncology department, and everyone knows what it means.

With Xu Yun and Lin Yi's familiarity, they naturally would not be restrained at this time, and directly asked about their specific situation.

"How is Academician Christian's health, has you found out the reason?"

"We have done the corresponding tests, and the final results will not come out for a while, but according to the preliminary judgment, it may be liver cancer." In the face of Xu Yun's inquiry, Lin Yi replied truthfully: "And the situation is not very optimistic, I'm afraid it's already in the late stage." ”

Hearing this result, Xu Yun couldn't help frowning, but he didn't expect the other party to have cancer.

Liver cancer is relatively easy to treat in the early stage, and even with traditional treatment regimens, there is basically no big problem.

However, liver cancer is not easy to detect in the early stage, and it is often at an advanced stage by the time it is detected, so the situation becomes very difficult.

But soon, Xu Yun cleared these thoughts from his mind.

Anyway, there is a new chimeric antigen receptor T-cell immunotherapy technology, and there is still a greater certainty of curing Christian.

It's just that Christian came here this time mainly to study the changes in the patient's body after using this technology, and now he is the subject of research.

I don't know if this is a good thing or a bad thing for him.

"Then let's wait for the results to come out."

Xu Yun thought for a moment and decided to wait for the results of the examination to determine Christian's true condition before telling the other party about it.

With Lin Yi's help, they didn't wait long, and it didn't take long for the inspection report to be uploaded to the hospital system.

As Lin Yi judged, Christian is indeed liver cancer and it is more serious.

Xu Yun didn't delay when he got the results, and even came to the ward where Christian was.

"Academician Christian, I have a good news and a bad news here, I don't know which one you want to hear first?"

Looking at Christian, who was already sitting up on the hospital bed, Xu Yun wanted to liven up the atmosphere and said this.

Although Christian's hair was already silvery, and he was completely combed behind his ears to reveal a shiny forehead, his heart did not resemble that of an old man at all.

After hearing Xu Yun's words, he immediately became interested, and made a choice very cooperatively.

"Let's hear the bad news first."

"The bad news is that you've just been tested for liver cancer, and here's the test report."

Xu Yun didn't deliberately tactfully, he said the matter directly, and handed the inspection report to the other party.

However, without waiting for the other party to choose another news, he smiled again and said: "The good news is that it can be treated with the technology of our laboratory, so Academician Christian, please rest assured." ”

After experiencing such a completely different news, everyone thought that Christian would be at a loss, but the other party shouted excitedly in the next second.

"It's just amazing."

"Xu."

"I want to be able to do it in the lab, which will allow me to better record the changes and reactions in my body."

His whole face was full of joy, and he was not worried about his cancer detection in the slightest.

And Paina, who followed this scene to see it, also understood why DeepTech's new chimeric antigen receptor T-cell immunotherapy was the trend in the future.

In the face of a relatively serious liver cancer patient, they can still be treated with confidence, which is something that their Pfizer anti-cancer drugs cannot do.

……

(End of chapter)